To ensure sustainability, we expanded into getting our hands dirty and establishing our own in-house R&D arm. What appeared as just a research project in 2013, had resulted in us having more products and future pipelines to offer to our potential clients. To date, we have developed a range of new product derivatives out of our core technologies, enabling us to cater to wider audience while offering solutions to previously unmet medical needs. Several research projects are still ongoing and a few more are also in the pipelines. We welcome new partnership in research as well as funders to support our growth.
We are actively involved, from detecting illness and determining disease to providing treatments and monitoring progress of therapy.